STOCK TITAN

electroCore to Participate in Upcoming Investor Conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
electroCore, Inc. (ECOR) announces participation in upcoming investor conferences. Chief Strategy Officer Joshua Lev and CEO Dan Goldberger to attend Roth and Needham conferences for investor meetings and company presentations.
Positive
  • None.
Negative
  • None.

ROCKAWAY, N.J., March 12, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that the Company’s Chief Strategy Officer, Joshua Lev, is scheduled to attend the 36th Annual Roth Conference taking place at The Ritz Carlton Laguna Niguel in Dana Point, California on March 17 – 19, 2024. electroCore will host 1x1 investor meetings on March 18 and 19, 2024. Please contact Roth MKM to schedule a 1x1 meeting.

In addition, Dan Goldberger, CEO of electroCore, Inc. is scheduled to participate in the 23rd Annual Needham Virtual Healthcare Conference on April 8 – 11, 2024. Mr. Goldberger will give a company presentation on April 8th at 3:00 pm and will host 1x1 investor meetings throughout the conference. Please contact Needham to schedule a 1x1 meeting.

About electroCore, Inc.
electroCore, Inc. is a commercial stage bioelectronic medicine and wellness company dedicated to improving health through its non-invasive vagus nerve stimulation (“nVNS”) technology platform. Our focus is the commercialization of medical devices for the management and treatment of certain medical conditions and consumer product offerings utilizing nVNS to promote general wellbeing and human performance in the United States and select overseas markets.

For more information, visit www.electrocore.com.

Contact:
ECOR Investor Relations
(973) 302-9253
investors@electrocore.com


The 36th Annual Roth Conference is scheduled to take place on March 17 - 19, 2024.

The Roth Conference will be held at The Ritz Carlton Laguna Niguel in Dana Point, California.

Chief Strategy Officer Joshua Lev is scheduled to attend the Roth Conference.

electroCore will host 1x1 investor meetings on March 18 and 19, 2024.

The 23rd Annual Needham Virtual Healthcare Conference is scheduled for April 8 - 11, 2024.

CEO Dan Goldberger of electroCore, Inc. is scheduled to participate in the Needham Virtual Healthcare Conference.

Dan Goldberger will give a company presentation on April 8th at 3:00 pm.

electroCore will host 1x1 investor meetings throughout the Needham Virtual Healthcare Conference.
ElectroCore Inc

NASDAQ:ECOR

ECOR Rankings

ECOR Latest News

ECOR Stock Data

Electromedical and Electrotherapeutic Apparatus Manufacturing
Manufacturing
Health Technology, Medical Specialties, Manufacturing, Electromedical and Electrotherapeutic Apparatus Manufacturing
United States

About ECOR

electrocore is, a us based electroceutical healthcare company, which is developing a range of non-invasive vagus nerve stimulation (nvns) patient administered therapies for the treatment of multiple conditions in neurology, psychiatry, gastroenterology and other fields. initial focus is on primary headache (migraine and cluster headache), with trials continuing in epilepsy, gastric motility disorders, depression and anxiety. electrocore, which was founded in 2005, has more than 30 employees and full time consultants with offices in the us (head office), germany (german and european head office), uk, italy, australia, and canada.